Last Updated: November 7, 2023
We are thrilled to announce a significant milestone in our ongoing research at Loda's Lab.
Last Updated: November 13, 2023
Circulating cell-free methylated DNA (cfmeDNA) is a promising new biomarker for cancer detection, diagnosis, and monitoring.
Last Updated: February 26, 2024
We have developed, pioneered and disseminated several techniques in molecular pathology.
Last Updated: November 6, 2023
While progression from normal prostatic epithelium to invasive cancer is driven by molecular alterations, tumor cells and cells in the cancer microenvironment are co-dependent and co-evolve.
Last Updated: November 6, 2023
Genetic alterations in cancer define specific metabolic pathways that support their survival and growth.